How many investments has Cancer Fund made?

Cancer Fund has 8 tracked investments.

What stage does Cancer Fund invest at?

Cancer Fund invests at the Seed, Series A, Series B, Series C stages.

Where is Cancer Fund located?

Cancer Fund is headquartered in Phoenix, US.

Who does Cancer Fund co-invest with?

Cancer Fund most often shares deals with Y Combinator, AlleyCorp, Good Growth Capital, among 32 tracked co-investors.

Cancer Fund

Impact investor

Phoenix · Seed–Series C · 11 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Cancer Fund

1,421 people in our graph share verified history with the Cancer Fund team — schools, employers, funds. One of them is your warm intro.

Ayshaunlockedknows Prashanth Kini · together at Oracle (overlapped)

×4knows the team · via Oracle

knows the team · via Northwestern University

knows the team · via Procter & Gamble Co

×2knows the team · via DePaul University

×2knows the team · via SDA Bocconi

✨ Fox Verdict

Investment thesis

Cancer Fund backs early-stage oncology companies, focusing on pre-clinical and early-clinical innovations primarily at the Seed through Series A stages. It invests through Cancer Fund I, LLC, a 10-year fund term vehicle open to verified accredited investors, and complements this with a venture-giving donor-advised fund allowing anyone to support cancer innovation. The firm emphasizes patient capital at the earliest stages to fund proof points that unlock later development, and is supported by a 10,000+ community of physicians, scientists, survivors, and impact investors who help evaluate and follow the companies it funds across diagnostics, therapeutics, and remote monitoring.

Invests inBiotech Digital Health Healthtech Impact & Social Good Medical Devices Global Phoenix United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series C

Phoenix, US

Instruments

Equity · Grants

Tracked investments

Team · 11 people

from the firm's website & curated

Ann Low· Co-Founder, The Lowdown on Cancer host· Scottsdale, Arizona, United Statesin

Serial entrepreneur, author, and cancer advocate who wrote a guidebook for newly diagnosed cancer patients after her own 2014 diagnosis. She previously served nearly a decade as Executive Director of the Phoenix nonprofit Hearts of Stone.

Anthony Bajoras· Founder, Managing Director· Scottsdale, Arizona, United Statesin

Founder of Cancer Fund and Managing Director of Cancer Fund I, with 20+ years building early-stage ventures across medical device, pharmaceutical, bioinformatics, wellness, and healthcare IT/IoT companies. He holds a BS in Business Management & Entrepreneurship from DePaul University with additional studies at ASU, IIT, and Northwestern.

Jeff Rea· Co-Founder, Stakeholder Engagement· Scottsdale, Arizona, United Statesin

Co-founder focused on stakeholder engagement across the community, investors, and innovators. A former Fortune 50 executive turned entrepreneur, he holds an MBA from Northwestern's Kellogg School and a BBA from Washington State University.

Yifan Zhao· Founder & Managing Director· Baarn, Utrecht, Netherlandsin

Yifan Zhao is the Founder and Managing Director of CANCER FUND Impact Investments®, an organization focused on cancer innovation and patient outcomes with a community of more than 10,000 stakeholders, including physicians, researchers, survivors, caregivers, and investors. Under Zhao's leadership, the firm has made 11 investments across 8 portfolio companies.

Avi Dukler· Venture Partner

Venture partner and seasoned entrepreneur with 25 years in healthtech focused on inflammation and autoimmunity, and a founder of biotech and clinical diagnostics companies. He earned a PhD in biotechnology from Tel-Aviv University.

Edward Cho· Venture Partner

Venture partner and cancer researcher with 20+ years in life sciences. He is Head of Biologics Development at Detect, Inc. and Co-Founder/Chief Scientific Officer at Spin Bio, and holds a PhD in Molecular Medicine/Cancer Biology.

Jennifer Lee· Venture Partner

Venture partner with two decades helping translate science into therapies, having contributed to seven FDA approvals. She invests in science and technology companies with global impact and holds degrees from the University of Illinois and Northwestern.

John Anagnostis· Venture Partner· New Jerseyin

Venture partner with an economics and finance background and roughly ten years of venture experience investing from seed to Series D. He holds an MBA from SDA Bocconi in Milan.

Prashanth Kini· Venture Partner· North Miami Beach, Florida, United Statesin

Venture partner with 25+ years in healthcare and life-sciences technology, including product and business development leadership roles and private equity investing in oncology real-world data. He holds a PhD in Electrical and Computer Engineering from the University of Cincinnati.

Vinona Bhatia· Venture Partner

Venture partner and hematologist-oncologist with expertise in precision oncology and health equity. She founded P4CI advising early-stage oncology companies and serves as an LP and advisor at How Women Invest and Coyote Ventures.

James McCabe· Venture Partner· Pinehurst, North Carolina, United Statesin

James McCabe is a healthcare and life sciences technology executive whose work spans product strategy, M&A diligence and integration, AI/ML commercialization, SaaS transformation, and cloud platform delivery across enterprise, startup, and private equity settings. He currently serves as a Venture Partner at Cancer Fund, where his focus includes agentic AI applications in healthcare workflows and the governance frameworks supporting their use. He collaborates with founders, investors, and health-system leaders on the implementation of these systems.

What they invest in

from 6 of 8 portfolio companies

Medical Devices ×5Biotech ×4Healthtech ×4AI & Machine Learning ×3Digital Health ×3Deep Tech ×1Hardware ×1SaaS ×1

HQs:United States×4

Who they back

founder profiles across 5 portfolio companies

Accelerator rootsportfolio companies that came through a program

Y Combinator ×2

Investments · 8 tracked

founders shown can be your intro path

AOA Dxaoadx.com in 𝕏

AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US

Oriana Papin-Zoghbi(Founder)in Alex Fisher(Founder/COO)in Anna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)in

Board Surbhi Sarna(Director)in

Co-investorsAlleyCorp Good Growth Capital Joyance Partners Y Combinator Astia Aurum Venture Partners +19 more

Avesta76avestabio.com

Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs.

BiotechHealthtech

March Biosciencesmarch.bio in

March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.

BiotechMedical DevicesHouston, US

Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)

Board Thomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)

Co-investorsMission Biocapital 4BIO Capital Fitz Gate Ventures Modi Ventures Portal Innovations TMC Venture Fund +1 more

NearWavenearwave.co in 𝕏

NearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications.

AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesSaaSAustin, US

Roy Stillwell(Founder)in

Co-investors1842 Elevate Ventures Health Wildcatters IrishAngels Y Combinator

NxGenPortnxgenport.com in

NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis.

AI & Machine LearningDigital HealthMedical Devices

Cathy Skinner(Co-founder/Co-inventor & Chief Executive Officer)Rosanne Welcher(Co-founder/Co-inventor & Chief Operating Officer)in

Co-investorsGROOVE CAPITAL

Reglagenereglagene.com in

Reglagene develops a brain-penetrant oral drug therapy designed to treat primary tumors and brain metastases in patients with cancer.

BiotechDigital HealthHealthtechMedical DevicesOro Valley, US

Vijay Gokhale(Co-Founder)inRichard Austin(Chief Executive Officer/President/Co-Founder)inLaurence Hurley(Co-Founder)

Co-investorsTech Coast Angels

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CellensVeana

Portfolio news

latest coverage across their companies

Top 10 Oncology Capital Raises and Investors in the U.S. - January 1st - 31st, 2026

Reglagene · castleplacement.com · Feb 18, 2026

Frequently asked questions

How many investments has Cancer Fund made?: Cancer Fund has 8 tracked investments.
What stage does Cancer Fund invest at?: Cancer Fund invests at the Seed, Series A, Series B, Series C stages.
What sectors does Cancer Fund focus on?: Cancer Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
Where is Cancer Fund located?: Cancer Fund is headquartered in Phoenix, US.
Who does Cancer Fund co-invest with?: Cancer Fund most often shares deals with Y Combinator, AlleyCorp, Good Growth Capital, among 32 tracked co-investors.

Images

Similar investors

Innovestor Ventures

Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.

$270K – $3.2M

Novo Holdings

Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.

$1.1M – $54M

MDI Ventures

MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.

$500K – $75M

Asabys Partners

Asabys Partners is a healthcare and life sciences venture capital firm that invests in innovative science and medical technologies to improve patients' lives.

B4 Capital

$10M – $50M